---
$id: https://graph.org.ai/products/commodity/51111703
$type: Product
source: UNSPSC
code: "51111703"
title: "Daunorubicin citrate"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Daunorubicin citrate

**UNSPSC Code**: 51111703
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic with the molecular formula C27H29NO10.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5L84T2Z6NP. European Medicines Agency schedules daunorubicin citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB22734. The term daunorubicin citrate is a U.S. FDA designation. Most nations schedule daunorubicin citrate under HS 29419000 and SITC 54139. As of Q4 2014, DAUNORUBICIN CITRATE remains the US FDA Preferred Term for this commodity. Daunorubicin citrate bears US NLM identifiers UMLS ID C1289972 and NCI Concept Code C47471. SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

